2014 Volume 67 Issue 10 Pages 877-887
The treatment of patients with liver metastases from colorectal cancer continues to evolve. However, while surgical resection alone is regarded as the standard of care for patients with liver metastases of colorectal cancer relapse is common. Recently, the use of novel agents as a first-line treatment in metastatic colorectal cancer has generated cautious optimism in the field of oncology. This review describes perioperative chemotherapy for patients with liver metastases of colorectal cancer.